North Carolina Drug Injury Attorney

North Carolina Consumer Based law Firm

There have been a variety of drug injuries in the news of late with a variety of drug manufacturers in the spotlight. The pharmaceutical industry is hugely competitive. Drug manufacturing giants aggressively market their products, often with their eyes strictly on profits. Specific health risks associated with their “wonder drugs” are frequently downplayed or hidden from the public. All too often, the FDA (www.fda.gov) must request stricter warning labels, only to pull the drug off the market months later. However, by the time of these drug recalls, many case reports of drug injury and even death have accumulated.

A North Carolina drug injuries attorney at Crumley & Associates handles pharmaceutical cases because the public deserves justice when drug companies are careless. Too many drugs have made headlines with their frightening side effects that include: primary pulmonary hypertension, hemorrhagic strokes, kidney damage, kidney failure and more.

Follow the links for information you need to know about some of these drug recalls and drug injuries.

HRT

HRT’s estrogen-progestin drug therapy has now been shown to significantly increase the risk for many alarming medical conditions. [read more]

Ortho Evra®

Ortho Evra® is the number one prescribed birth control brand in the United States (1). Ortho Evra is a birth control patch that is applied to the arms, torso, abdomen, or buttocks once a week and offers "the same efficacy as the pill with even greater simplicity (1)." It turns out, however, that women using the Ortho Evra patch are at an increased risk for fatal blood clots compared to women taking birth control pills. [read more]

Seroquel®

In January of 2004, four different organizations issued a warning regarding a study which linked six different atypical antipsychotic drugs to diabetes, obesity, and high cholesterol which can raise a person's risk of heart disease. The medical societies, which included the American Diabetes Association, the American Psychiatric Association, the North American Association for the Study of Obesity, and the American Association of Clinical  Endocrinologists, suggested that doctors closely monitor their patients after treatment is started for signs of adverse side effects. [read more]

For the most current information about drug safety and regulation, please visit the FDA’s Center for Drug Evaluation and Research (www.fda.gov/cder/index.html).